Educational Research Context
This page is provided for educational and informational purposes only. The information below is a summary of published peer-reviewed research and does not constitute medical advice, diagnosis, or treatment recommendations.
Educational Context
Important: The following information is for educational purposes only and does not constitute medical advice. These products are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before beginning any new wellness regimen.
Peptides are short chains of amino acids — the same building blocks the body uses to manufacture hormones, growth factors, and signaling proteins. The compounds in the Kenko catalog have been referenced in academic, sports science, and longevity research settings over varying periods.
Our role is to source these compounds to pharmaceutical-grade standards, document their published research context, and make that information available for educational purposes. We are not a pharmacy, we are not prescribers, and we do not provide medical advice.
The summaries below reflect published peer-reviewed research. They are provided as educational context only and should be reviewed alongside a qualified healthcare provider who can assess their appropriateness for your individual situation.
Our Sourcing Standards
We reference peer-reviewed research when evaluating compounds for our catalog. We summarize what is studied — not what is guaranteed. Individual responses vary and are not assured.
Every compound we carry has a documented mechanism of action in published literature. We present this as educational context, not as a claim about what the compound will do for any individual.
Compounds are sourced from manufacturers operating under pharmaceutical-grade standards. We vet every supplier and only carry compounds with established research histories in the published literature.
Our formulations reference concentration ranges cited in published research. This is educational context only and does not constitute a prescription or dosing recommendation.
We review available safety and tolerability data for every compound we carry. We do not carry compounds with concerning or uncharacterized safety profiles in the published literature.
We never make disease treatment claims. Every piece of copy on this site is written to reflect research context only — not to imply FDA approval, guaranteed outcomes, or medical treatment.
Research Summaries
The following summaries are for educational purposes only. They reflect published peer-reviewed research and do not constitute medical advice, diagnosis, or treatment recommendations. These products are not FDA-approved. Individual results vary.
Body Protection Compound 157 is a synthetic pentadecapeptide that has been referenced in preclinical research literature for over 30 years. It has been explored across multiple tissue types in animal model studies.
Commonly Studied For
Tissue wellness research — angiogenesis pathway signaling — growth factor receptor studies — gut wellness research — collagen-related pathway research — inflammatory signaling studies
Referenced research: Sikiric P, et al. (2020). Brain-gut Axis and Pentadecapeptide BPC 157. Current Neuropharmacology. | Huang T, et al. (2015). BPC-157 studies. Journal of Applied Physiology.
Not FDA-approved. Not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare provider before use. Individual results vary.
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring tripeptide that has been referenced in dermatology and longevity research for over 50 years, making it one of the most-studied peptides in skin wellness literature.
Commonly Studied For
Collagen synthesis pathway research — skin wellness gene expression studies — hair follicle research — wound healing pathway signaling — antioxidant activity research — cellular aging studies
Referenced research: Pickart L, et al. (2015). GHK-Cu: A Human Tripeptide with Multiple Biological Activities. BioMed Research International.
Not FDA-approved. Not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare provider before use. Individual results vary.
Nicotinamide Adenine Dinucleotide (NAD+) is an endogenous coenzyme present in all living cells. Published research has explored its role in cellular energy metabolism, DNA maintenance, and longevity-associated signaling pathways.
Commonly Studied For
Cellular energy research — sirtuin pathway studies — DNA maintenance research — mitochondrial function studies — longevity-associated pathway research — metabolic wellness signaling
Referenced research: Verdin E (2015). NAD+ in aging, metabolism, and neurodegeneration. Science. | Yoshino J, et al. (2018). NAD+ Intermediates. Cell Metabolism.
Not FDA-approved. Not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare provider before use. Individual results vary.
Retatrutide is a synthetic triple-receptor compound (GLP-1/GIP/Glucagon) currently under active clinical investigation by Eli Lilly. Phase 2 trial results have been published in peer-reviewed journals. It is not currently FDA-approved for commercial sale as a drug.
Commonly Studied For
Metabolic wellness research — GLP-1/GIP/Glucagon receptor signaling studies — body weight research — glycemic signaling research — energy expenditure studies
Referenced research: Jastreboff AM, et al. (2023). Triple-Hormone-Receptor Agonist Retatrutide for Obesity. New England Journal of Medicine. (Phase 2 trial data)
Not FDA-approved. Not a drug. Not intended to diagnose, treat, cure, or prevent any disease. For research and educational purposes only. Consult a healthcare provider before use.
AOD-9604 is a synthetic peptide fragment derived from the C-terminus of human growth hormone, commonly referenced in metabolic wellness and body composition research literature. It was the subject of clinical trials for obesity and passed Phase 3 with a favorable safety profile.
Commonly Studied For
Fat metabolism pathway research — lipolytic signaling studies — body composition research — adipose tissue pathway signaling — metabolic wellness studies
Referenced research: Ng FM, et al. (2000). Metabolic studies of a hGH fragment. Journal of Molecular Endocrinology. | Heffernan M, et al. (2001). AOD-9604 in obese subjects. International Journal of Obesity.
Not FDA-approved. Not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare provider before use. Individual results vary.
Educational Context
Peptides are short chains of amino acids — typically 2 to 50 amino acids linked by peptide bonds. The body naturally produces many peptides as signaling molecules, including insulin and oxytocin. The compounds we carry are synthetic analogues of these naturally occurring peptide structures.
Research peptides are typically explored in preclinical (animal) and clinical settings to study their interactions with specific biological pathways. The compounds we carry have published research histories — some spanning decades. We summarize that research as educational context only.
Most research peptides are supplied in lyophilized (freeze-dried) form for stability during storage and shipping. Before use, they are reconstituted with bacteriostatic water. Full reconstitution instructions are included with every order in the research reference guide.
We strongly encourage anyone exploring peptide compounds to do so in consultation with a qualified healthcare provider. Our reference guides are educational tools — they are not prescriptions, treatment plans, or medical advice of any kind.
Published Research Highlights
The following are excerpts from published peer-reviewed research, summarized for educational context only. These findings reflect research outcomes in specific study conditions and do not predict or guarantee outcomes for any individual. Not medical advice.
“BPC-157 demonstrated accelerated tissue organization and new tissue formation in tendon defect models, with collagen structure observed in treated groups.”
Adapted from: Chang CH, et al. — Journal of Applied Physiology (2011)
Preclinical research. Does not predict human outcomes. Not medical advice.
“GHK-Cu was associated with increased collagen synthesis activity and changes in gene expression profiles related to skin aging in human fibroblast cell cultures.”
Adapted from: Pickart L & Margolina A — BioMed Research International (2018)
In vitro research. Does not predict human outcomes. Not medical advice.
“NAD+ precursor supplementation was associated with changes in mitochondrial function markers and metabolic parameters in aged study models.”
Adapted from: Gomes AP, et al. — Cell (2013)
Preclinical research. Does not predict human outcomes. Not medical advice.
“In a Phase 2 randomized trial, participants receiving the highest retatrutide dose had a mean percentage change in body weight of −24.2% at week 48.”
Adapted from: Jastreboff AM, et al. — New England Journal of Medicine (2023) — Phase 2 trial
Clinical trial data. Individual results in research conditions may differ from personal use outcomes. Not medical advice.